1701 -- Stop Higher Education Espionage and Theft Act of 2019 | Poliscope

Stop Higher Education Espionage and Theft Act of 2019

1701

116th Congress

Education

In Committee

Legislative Progress

✓

Introduced

Committee

Floor Vote

Other Chamber

Enacted

Introduced

June 3, 2019

Latest Action

June 3, 2019

Primary Sponsor

Ted CruzRepublican(TX)

Momentum (last 30 days)

score

0 actions · 0 new cosponsors · 0 votes

Speed vs cohort

0pct

0d open

vs 5,086 other S bills in the 116th — cohort avg 30d

Summary

Stop Higher Education Espionage and Theft Act of 2019 This bill establishes a process for designating foreign actors as foreign intelligence threats to higher education. Specifically, the Federal Bureau of Investigation (FBI) must designate a foreign actor as a foreign intelligence threat to higher education if the foreign actor has committed, attempted to commit, or conspired to commit certain actions in connection with an institution of higher education (IHE), such as espionage, misuse of visas, or theft of trade secrets. Prior to making such a designation, FBI must submit notice to congressional leaders and the Department of Justice. Upon the designation of a foreign actor as such a threat, the Department of State must revoke the nonimmigrant visa issued to such foreign actor present in the United States, and the Department of Homeland Security must initiate removal proceedings against the foreign actor. The bill provides for judicial review and a process for revoking a foreign actor's designation as such a threat. It also requires an IHE to disclose to the Department of Education any gift or contract with a foreign intelligence threat, including the fair market value of the gift or contract.

Lobbying filings that explicitly cite this bill (5)

These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.

Filing registrants (2)

KOUNTOUPES DENHAM CARR & REID, LLC (4)AMERICAN CHEMICAL SOCIETY (ACS) (1)

BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY)client→KOUNTOUPES DENHAM CARR & REID, LLC

2024 · fourth_quarter · Health Issues

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to the No Surprises Act (Public Law 116-260) and patient protections. Issues related to agency funding for medical and cancer research. Issues related to H.R.4758/S.2372, The Accelerating Kids' Access to Care Act. Issues related to clinical trial diversity, including H.R. 3503/S.1701, The NIH Clinical Trial Diversity Act. Issues related to the pharmaceutical supply chain and drug shortages. Issues related to pediatric drug development.